Viewing StudyNCT05051904



Ignite Creation Date: 2024-05-06 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 2:14 PM
Study NCT ID: NCT05051904
Status: COMPLETED
Last Update Posted: 2024-03-07
First Post: 2021-09-15

Brief Title: A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran Rivaroxaban or Warfarin
Sponsor:
Organization: Boehringer Ingelheim

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 39357
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
79073
Who Masked List: